Clinical Trial Update: A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating selexipag as add-on therapy to standard of care for children with pulmonary arterial hypertension. The sponsor is Actelion and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Selexipag (Uptravi) (Selexipag)

Snippet

Sponsor: Actelion | Conditions: Hypertension, Pulmonary | Phase 3 | Status: ACTIVE_NOT_RECRUITING